Zacks.com featured highlights include Clarivate, Expedia Group and Haemonetics

For Immediate Release

Chicago, IL January 25, 2023 Stocks in this weeks article are Clarivate Plc CLVT, Expedia Group EXPE and Haemonetics Corp. HAE.

Time to Pick Up These 3 Top Relative Price Strength Stocks

We know that the market witnessed a broad-based decline in 2022 owing to a high-interest-rate regime and tighter monetary control adopted by the Fed to combat a 40-year high inflation. But as we have entered 2023, a very early sign of a rebound is visible on Wall Street, with peak inflation seemingly behind us. As proof of this, the S&P 500 which tracks the biggest U.S.-listed companies has crept above 4K for the first time in several weeks.

In particular, the market participants see a pending 25 basis-point interest rate hike next week as a sign of slowing Fed tightening, providing a much-needed respite to the economy. Yet, despite the central bank's softening stance, traders and investors continue to see headwinds in the form of softness in consumer spending, worries over a tight labor market and disappointing fourth-quarter 2022 earnings numbers. As such, extremely volatile trading in U.S. markets is expected to continue for some time.